Vivo Capital, LLC Q4 2021 Filing
Filed February 11, 2022
Portfolio Value
$1.7T
Holdings
55
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (55 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TILInstil Bio Inc | 12,486,787 | $213.6B | 12.88% | |
| 2 | HRMYHarmony Biosciences Holdings Inc | 4,884,341 | $208.3B | 12.56% | |
| 3 | —New Frontier Health Corp | 14,300,000 | $163.9B | 9.88% | |
| 4 | OPHTEURIveric Bio Inc | 6,290,827 | $105.2B | 6.34% | |
| 5 | ALXOALX Oncology Holdings Inc | 4,220,048 | $90.7B | 5.47% | |
| 6 | TARSTarsus Pharmaceuticals Inc | 2,987,331 | $67.2B | 4.05% | |
| 7 | AMRSEURAmyris, Inc | 11,642,195 | $63.0B | 3.80% | |
| 8 | ASNDAscendis Pharma A/S | 442,502 | $59.5B | 3.59% | |
| 9 | ALGSAligos Therapeutics Inc | 3,547,030 | $42.1B | 2.54% | |
| 10 | —Sierra Oncology, Inc | 1,917,074 | $41.7B | 2.51% | |
| 11 | —Genetron Holdings Ltd | 6,339,860 | $38.7B | 2.33% | |
| 12 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 2.30% | |
| 13 | VTYXVentyx Biosciences Inc | 1,791,275 | $35.6B | 2.15% | |
| 14 | WHWKAadi Bioscience Inc | 1,303,390 | $31.5B | 1.90% | |
| 15 | VRDNViridian Therapeutics Inc | 1,300,000 | $25.7B | 1.55% | |
| 16 | —Impel NeuroPharma Inc | 2,884,789 | $24.9B | 1.50% | |
| 17 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $23.7B | 1.43% | |
| 18 | KALVKalVista Pharmaceuticals Inc. | 1,533,559 | $20.3B | 1.22% | |
| 19 | RLMDRelmada Therapeutics Inc | 882,352 | $19.9B | 1.20% | |
| 20 | IOBTIO Biotech Inc | 3,015,545 | $19.3B | 1.16% | |
| 21 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $19.0B | 1.14% | |
| 22 | TERNTerns Pharmaceuticals Inc | 2,675,133 | $18.9B | 1.14% | |
| 23 | TCE2Celldex Therapeutics Inc | 484,453 | $18.7B | 1.13% | |
| 24 | VRNAVerona Pharma PLC | 2,749,918 | $18.5B | 1.11% | |
| 25 | COGTCogent Biosciences Inc | 1,920,941 | $16.5B | 0.99% | |
| 26 | OLMAOlema Pharmaceuticals Inc | 1,689,515 | $15.8B | 0.95% | |
| 27 | 290AChinook Therapeutics Inc | 872,151 | $14.2B | 0.86% | |
| 28 | MRUSMerus NV | 442,000 | $14.1B | 0.85% | |
| 29 | ACRSAclaris Therapeutics, Inc. | 920,982 | $13.4B | 0.81% | |
| 30 | SERASera Prognostics Inc | 1,856,011 | $12.8B | 0.77% | |
| 31 | CDXSCodexis, Inc | 388,144 | $12.1B | 0.73% | |
| 32 | LEGNLegend Biotech Corp Sponsored | 244,375 | $11.4B | 0.69% | |
| 33 | —Minerva Surgical Inc | 2,215,667 | $11.4B | 0.69% | |
| 34 | DSGNDesign Therapeutics | 530,991 | $11.4B | 0.69% | |
| 35 | MREOMereo Biopharma Group PLC | 6,907,189 | $11.1B | 0.67% | |
| 36 | ZLABZai Lab Ltd ADR | 174,999 | $11.0B | 0.66% | |
| 37 | EPIEUREssa Pharma Inc | 744,058 | $10.6B | 0.64% | |
| 38 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $9.1B | 0.55% | |
| 39 | —Dice Therapeutics Inc | 326,272 | $8.3B | 0.50% | |
| 40 | BLUBellus Health Inc | 1,017,152 | $8.2B | 0.49% | |
| 41 | NKTXNkarta Inc | 512,225 | $7.9B | 0.47% | |
| 42 | DYNDyne Therapeutics Inc | 577,642 | $6.9B | 0.41% | |
| 43 | CMPXCompass Therapeutics Inc | 2,000,000 | $6.3B | 0.38% | |
| 44 | GRCLGracell Biotechnologies Inc | 961,359 | $5.8B | 0.35% | |
| 45 | IOVAIovance Biotherapeutics Inc | 301,000 | $5.7B | 0.35% | |
| 46 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $5.5B | 0.33% | |
| 47 | —Zymeworks Inc | 286,064 | $4.7B | 0.28% | |
| 48 | LRMRLarimar Therapeutics Inc | 399,830 | $4.3B | 0.26% | |
| 49 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $3.2B | 0.19% | |
| 50 | FIXXEURHomology Medicines, Inc. | 853,143 | $3.1B | 0.19% | |
| 51 | —Elevation Oncology Inc | 496,844 | $3.0B | 0.18% | |
| 52 | —Zogenix Inc | 105,000 | $1.7B | 0.10% | |
| 53 | DTILPrecision Biosciences Inc | 140,255 | $1.0B | 0.06% | |
| 54 | —Metacrine Inc | 146,426 | $99.0M | 0.01% | |
| 55 | CLDNEUREiger BioPharmaceuticals Inc | 4,166 | $22.0M | 0.00% |